Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour
Wagner, Andrew J., Agulnik, Mark, Heinrich, Michael C., Mahadevan, Daruka, Riedel, Richard F., von Mehren, Margaret, Trent, Jonathan, Demetri, George D., Corless, Christopher L., Yule, Murray, Lyons,Volume:
61
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2016.03.076
Date:
July, 2016
File:
PDF, 634 KB
english, 2016